SGK1 and major depressive disorder: Therefore, we cannot conclude whether inhibiting SGK1 or promoting it is conducive to the recovery of MDD, but it is undeniable that SGK1 participates in the important process of MDD pathogenesis and is a potential target for MDD treatment.